Sclerosing Bone Dysplasia Affecting the Mandible: a Rare but Distinctive Skeletal Abnormality

Author(s):  
Jorge Esquiche León ◽  
Luciana Yamamoto Almeida ◽  
Rafael Augusto Ferreira ◽  
Lucas Ribeiro Teixeira ◽  
Rodrigo Neves-Silva ◽  
...  
2003 ◽  
Vol 27 (3) ◽  
pp. 203-205 ◽  
Author(s):  
Sandeep Ghai ◽  
Raju Sharma ◽  
Sangeet Ghai

Author(s):  
E.R. Marqués Aparicio ◽  
J. Dolado Ardit ◽  
A. Crespo-Jara ◽  
A. Martínez Caballero ◽  
M.A. Antón Leal ◽  
...  

Bone ◽  
2014 ◽  
Vol 68 ◽  
pp. 142-145 ◽  
Author(s):  
Marie-Hélène Gannagé-Yared ◽  
Periklis Makrythanasis ◽  
Eliane Chouery ◽  
Cristina Sobacchi ◽  
Cybel Mehawej ◽  
...  

2017 ◽  
Vol 15 (4) ◽  
pp. 335-342 ◽  
Author(s):  
Anupam Kotwal ◽  
Bart L. Clarke

Orthopedics ◽  
1981 ◽  
Vol 4 (1) ◽  
pp. 100-100
Author(s):  
Wilton H Bunch

2010 ◽  
Vol 25 (3) ◽  
pp. 676-680 ◽  
Author(s):  
Eliane Chouery ◽  
Alessandra Pangrazio ◽  
Annalisa Frattini ◽  
Anna Villa ◽  
Liesbeth Van Wesenbeeck ◽  
...  

2019 ◽  
Vol 1 (2) ◽  
pp. 35-40
Author(s):  
Shahed Morshed ◽  

We report a 26-year-old male who was initially diagnosed as osteopetrosis and referred for endocrine evaluations. But due to specific clinical features supported by investigations, we diagnosed the case as sclerosteosis. The patient was managed by a multidisciplinary team approach. Sclerosteosis may be erroneously diagnosed as osteopetrosis. However, many unique features make it a separate entity.


2019 ◽  
Author(s):  
Helen Casey ◽  
Angus Stirling ◽  
Stephen Gallacher ◽  
Andrew Gallagher

2020 ◽  
Vol 105 (3) ◽  
pp. 688-695 ◽  
Author(s):  
Hui Peng ◽  
Zandra A Jenkins ◽  
Ruby White ◽  
Sam Connors ◽  
Matthew F Hunter ◽  
...  

Abstract Context The WNT/β-catenin pathway is central to the pathogenesis of various human diseases including those affecting bone development and tumor progression. Objective To evaluate the role of a gain-of-function variant in CTNNB1 in a child with a sclerosing bone dysplasia and an adrenocortical adenoma. Design Whole exome sequencing with corroborative biochemical analyses. Patients We recruited a child with a sclerosing bone dysplasia and an adrenocortical adenoma together with her unaffected parents. Intervention Whole exome sequencing and performance of immunoblotting and luciferase-based assays to assess the cellular consequences of a de novo variant in CTNNB1. Main Outcome Measure(s)/Result A de novo variant in CTNNB1 (c.131C>T; p.[Pro44Leu]) was identified in a patient with a sclerosing bone dysplasia and an adrenocortical adenoma. A luciferase-based transcriptional assay of WNT signaling activity verified that the activity of β-catenin was increased in the cells transfected with a CTNNB1p.Pro44Leu construct (P = 4.00 × 10–5). The β-catenin p.Pro44Leu variant was also associated with a decrease in phosphorylation at Ser45 and Ser33/Ser37/Thr41 in comparison to a wild-type (WT) CTNNB1 construct (P = 2.16 × 10–3, P = 9.34 × 10–8 respectively). Conclusion Increased β-catenin activity associated with a de novo gain-of-function CTNNB1 variant is associated with osteosclerotic phenotype and adrenocortical neoplasia.


Sign in / Sign up

Export Citation Format

Share Document